These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 7638777

  • 21. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature].
    Blanco Y, Ramos-Casals M, García-Carrasco M, Cervera R, Font J, Ingelmo M.
    Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151
    [Abstract] [Full Text] [Related]

  • 22. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL.
    Ter Arkh; 2008 Sep; 80(10):60-7. PubMed ID: 19105418
    [Abstract] [Full Text] [Related]

  • 23. Bullous systemic lupus erythematosus with antiphospholipid syndrome.
    Kacalak-Rzepka A, Zaluga E, Maleszka R, Królicki A, Klimowicz A.
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):490-4. PubMed ID: 15196171
    [Abstract] [Full Text] [Related]

  • 24. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
    Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
    [Abstract] [Full Text] [Related]

  • 25. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN, Clark-Soloninka CA, Spitzer KA, Gladman DD, Urowitz MB, Laskin CA.
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [Abstract] [Full Text] [Related]

  • 26. Antiphospholipid syndrome and recurrent thrombosis in children.
    Berkun Y, Padeh S, Barash J, Uziel Y, Harel L, Mukamel M, Revel-Vilk S, Kenet G.
    Arthritis Rheum; 2006 Dec 15; 55(6):850-5. PubMed ID: 17139660
    [Abstract] [Full Text] [Related]

  • 27. [The characteristics of kidney involvement in a female patient with systemic lupus erythematosus and the antiphospholipid syndrome].
    Kozlovskaia NL, Kabaenkova GS, Varshavskiĭ VA, Shvetsov MIu.
    Klin Med (Mosk); 1995 Dec 15; 73(3):93-6. PubMed ID: 8577127
    [Abstract] [Full Text] [Related]

  • 28. Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report.
    Motta S, Monti M.
    Photochem Photobiol Sci; 2007 Nov 15; 6(11):1150-1. PubMed ID: 17973045
    [Abstract] [Full Text] [Related]

  • 29. [Cardiovascular risk factors in systemic lupus erythematosus and in antiphospholipid syndrome].
    Sarzi-Puttini P, Atzeni F, Carrabba M.
    Minerva Med; 2003 Apr 15; 94(2):63-70. PubMed ID: 12858154
    [Abstract] [Full Text] [Related]

  • 30. [Systemic lupus erythematosus and antiphospholipid syndrome].
    Gröne HJ.
    Verh Dtsch Ges Pathol; 1996 Apr 15; 80():21-37. PubMed ID: 9065004
    [Abstract] [Full Text] [Related]

  • 31. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G, Cacoub P, Farnarier C, Marin V, Grégoire R, Gatel A, Durand JM, Harlé JR, Bongrand P, Piette JC.
    Arthritis Rheum; 2000 Jan 15; 43(1):55-64. PubMed ID: 10643700
    [Abstract] [Full Text] [Related]

  • 32. Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome.
    Hughson MD, McCarty GA, Sholer CM, Brumback RA.
    Mod Pathol; 1993 Nov 15; 6(6):644-53. PubMed ID: 8302806
    [Abstract] [Full Text] [Related]

  • 33. [Is the primary antiphospholipid syndrome a forerunner of SLE?].
    Tarr T, Muzes G, Pitlik E, Lakos G, Csépány T, Soltész P, Zeher M, Szegedi G, Kiss E.
    Orv Hetil; 2005 Jan 30; 146(5):203-7. PubMed ID: 15773587
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Catastrophic antiphospholipid syndrome. Communication of 2 forms of presentation].
    Grinberg AR, Heller PG, Correa G, Sarano JF, Molinas FC, Nicastro MA, Alvarez CL.
    Medicina (B Aires); 1999 Jan 30; 59(6):743-6. PubMed ID: 10752219
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Ocular manifestations in antiphospholipid syndrome.
    Suvajac G, Stojanovich L, Milenkovich S.
    Autoimmun Rev; 2007 Jun 30; 6(6):409-14. PubMed ID: 17537387
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.